| Novo Nordisk Pharma AG - Insulatard HM, Injektionssuspension | | 45495 | | 02 | | Insulatard HM | | Injektionssuspension | | A10AC01 | | Insulin (Human) | | 22.08.1986 | | |
| | Composition | | insulinum humanum ADNr isophanum 3.5 mg corresp. insulinum humanum ADNr isophanum 100 U.I., protamini sulfas, zinci chloridum, glycerolum, dinatrii phosphas dihydricus, natrii hydroxidum, acidum hydrochloridum, metacresolum, phenolum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium max. 0.78 mg. | | Packungsbestandteile | | Injection suspension | | | | | | | | Active Agent | Dose |
|---|
| Insulinum Humanum adnr Isophanum | 3.5 mg/ml correspond Insulinum Humanum adnr Isophanum 100 UI/ml |
| | BAG: Active Agent | Dose |
|---|
| Insulinum Humanum adnr Isophanum | 100 UI |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Disodium Phosphate Dihydrate | | Glycerol | | Metacresol | | Sodium Hydroxide | | Phenol | | Protamini Sulfas | | Zinc Chlorideate |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 10 ml | | | B | | Yes | | 035 | Durchstechflasche(n) à 10 ml | 11.41 | 28.85 | B | SL | No |
|
|